African American patients have a worse outcome, regardless of the molecular subtype of cancer. In White patients molecular subtypes were associated with better outcomes.
Read More
Among women with endometrial cancer (EC), African American or Black (AAoB) population share a disproportionate burden of cancer deaths. Here, we aim to focus on molecular differences between racial groups, specifically in Type 1 EC (T1EC).
Read More
Combining traditional next generation sequencing with optical genome mapping presents a robust picture of the precise genomic alterations.
Read More
A rare pediatric soft tissue tumor was analyzed to determine therapeutic targets. By combining multiple types of analysis, it was uncovered that this patient was eligible for a novel clinical trial containing MEK and PD-L1 checkpoint inhibitors.
Read More
Acute Myeloid Leukemia (AML) constitutes 15-20% of all pediatric acute leukemias, with an average survival rate of 70%. However, the black/African American subgroup do significantly worse than whites with AML.
Read More
Protean BioDiagnostics develops AI approach to detect specific EGFR mutations in lung cancer specimens using analysis of digital pathology images and will present findings at the AACR meeting.
Read More